Special Feature

User Panel

My Panel

My Panel

Bookmark Science Articles

Recent News
Bookmark / Share This Science Site

Reduction of serum ghrelin concentration during interferon-alpha therapy in patients with chronic hepatitis C.

Reduction of serum ghrelin concentration during interferon-alpha therapy in patients with chronic hepatitis C. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

  • Abstract Text of This Paper
  • Journal Published
  • MeSH Keywords of This Abstract
  • Chemicals and Substances Used in this Paper
  • Grants and Granting Agency of this Research
  • Database Accession Numbers Used in this Paper
  • Related Papers
  • Related Research Tags
  • Rate this Research Paper
  • Reduction of serum ghrelin concentration during interferon-alpha therapy in patients with chronic hepatitis C. Abstract Text:

    hisayoshi watanabeHisayoshi Watanabe,takafumi saitoTakafumi Saito,testuru karasawaTesturu Karasawa,shun kudoShun Kudo,kuniaki nakanoKuniaki Nakano,jun-itsu itoJun-Itsu Ito,kazuhiko sugaharaKazuhiko Sugahara,koji saitoKoji Saito,hitoshi togashiHitoshi Togashi,sumio kawataSumio Kawata,

    The efficacy of interferon (IFN) therapy for chronic hepatitis C is dependent on compliance. Anorexia is an important adverse effect in determining compliance. To clarify the mechanisms underlying anorexia, the level of ghrelin was determined during therapy. Fourteen patients with chronic hepatitis C received IFN-alpha2b with or without ribavirin (Rib+ or Rib- group; n=7 in each group) for 24 weeks. Serum ghrelin concentrations and body weight were determined before, 2 and 24 weeks after initiation of therapy. Serum ghrelin concentrations and body weight significantly decreased 2 weeks after initiation of therapy (P=0.0008 and 0.0062, respectively), and then returned to the level before therapy. The Deltaghrelin concentration correlated with Deltabody weight after 2 weeks (r=0.726, P=0.023). Percentage reduction of serum ghrelin was significantly higher in the Rib+ group than in the Rib- group (P=0.046). Percentage reduction in body weight tended to be higher in the Rib+ group (P=0.057). IFN-alpha2b therapy causes short-term reduction of serum ghrelin and body weight, and this may occur to a greater extent with combination therapy. Reduction of serum ghrelin might contribute partly to anorexia, leading to weight loss.

    Reduction of serum ghrelin concentration during interferon-alpha therapy in patients with chronic hepatitis C. Publishing Authors By Initials

    h watanabeH Watanabe,t saitoT Saito,t karasawaT Karasawa,s kudoS Kudo,k nakanoK Nakano,ji itoJI Ito,k sugaharaK Sugahara,k saitoK Saito,h togashiH Togashi,s kawataS Kawata,

    For similar abstracts research abstracts see: abstracts research

    PUBMED ID PMID:

    MEDLINE DATE:

    Reduction of serum ghrelin concentration during interferon-alpha therapy in patients with chronic hepatitis C. Journal Published:

    PUBLICATION TYPE: Journal Article

    Journal: Hepatology research : the official journal of the

    VOLUME: 33

    Page Numbers: 14-8

    Journal Abbreviation:

    ISSN: 1386-6346

    DAY: 19

    MONTH: 08

    YEAR: 2005

    Reduction of serum ghrelin concentration during interferon-alpha therapy in patients with chronic hepatitis C. Information

    Number of References:

    LANGUAGE: eng

    NlmUniqueID: 9711801

    Reduction of serum ghrelin concentration during interferon-alpha therapy in patients with chronic hepatitis C. Keywords Mesh Terms:

    KEYWORDS:

    MESH TERMS:

    Chemical & Substance for Abstract: Reduction of serum ghrelin concentration during interferon-alpha therapy in patients with chronic hepatitis C. Information

    Substance Name:

    Registry Number:

    Grant and Affiliation Information for Reduction of serum ghrelin concentration during interferon-alpha therapy in patients with chronic hepatitis C.

    AFFILIATION: Department of Gastroenterology, Faculty of Medicine, Yamagata University, 2-2-2 Iida-Nishi, Yamagata 990-9585, Japan.

    Country: Netherlands

    Netherlands Research PublicationNetherlands Research Publication

    AGENCY:

    GRANT:

    ACRONYM:

    MEDLINETA: Hepatol Res

    REFSOURCE:

    DATABASENAME:

    ACCESSION NUMBER:

    Number Hits: 0

    Reduction of serum ghrelin concentration during interferon-alpha therapy in patients with chronic hepatitis C Related Publications

     

    Molecular Station USER Menu

    Welcome to Molecular Station!

    You have to register before you can post on our forums or use our advanced features. Register Now! Its Free and Fast!

    Already registered? Login now below.

    User Name:

    Password:

    Already registered and Forgot your password? Click below to recover it.

    Recover Lost Password

    Join now - it's fast and free!

    Molecular Station is THE largest network of researchers, scientists and science lovers anywhere!

    Research Terms of Usage and Disclaimer
    Home
    Features

    Protocols

    DNA Forum

    Science Forum

    DNA Forum
    Biology Forum

    Science News


    [CaRP] XML error: Invalid document end at line 2

    For more click here:Science News